WhiteOak Capital Pharma and Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.07 %Nav, as on 12-12-2025

  • Previous Nav

  • Net Change on 12-12-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 -0.30 21.35 15.90 1.81 8,458.68
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 3.20 27.06 18.36 1.86 6,459.82
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 -0.18 20.77 15.92 1.93 2,812.12
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -1.03 21.78 15.94 2.10 1,338.85
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -1.23 23.83 15.73 2.25 1,126.13

Fund Holdings as on 30-November-2025

  • Sun Pharmaceutical Industries Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Max Healthcare Institute Limited

  • Clearing Corporation of India Ltd

  • Fortis Healthcare Limited

  • Laurus Labs Limited

  • Cipla Limited

  • Lupin Limited

  • Divi's Laboratories Limited

  • Neuland Laboratories Limited

  • Alkem Laboratories Limited

  • Sai Life Sciences Limited

  • Krishna Institute Of Medical Sciences Limited

  • Abbott India Limited

  • Shaily Engineering Plastics Limited

  • Ajanta Pharma Limited

  • Vijaya Diagnostic Centre Limited

  • Sudeep Pharma Limited

  • Emcure Pharmaceuticals Limited

  • Narayana Hrudayalaya Limited

  • Kovai Medical Center and Hospital Limited

  • Gland Pharma Limited

  • Pfizer Limited

  • Apollo Hospitals Enterprise Limited

  • Mankind Pharma Limited

  • Jupiter Life Line Hospitals Limited

  • AstraZeneca Pharma India Limited

  • Acutaas Chemicals Limited

  • Eris Lifesciences Limited

  • Poly Medicure Limited

  • Thyrocare Technologies Limited

  • Strides Pharma Science Limited

  • Navin Fluorine International Limited

  • Dr.Agarwals Eye Hospital Limited

  • 364 Days Tbill (MD 18/12/2025)

  • 182 Days Tbill (MD 25/12/2025)

  • Healthcare Global Enterprises Limited

  • Aether Industries Limited

  • Supriya Lifescience Limited

  • Shilpa Medicare Limited

  • Zota Health Care Limited

  • Anthem Biosciences Limited

  • Net Receivables / (Payables)

  • 91 Days Tbill (MD 15/01/2026)

  • 182 Days Tbill (MD 19/02/2026)

  • 91 Days Tbill (MD 04/12/2025)

  • Orchid Pharma Limited

  • Piramal Pharma Limited

  • 364 Days Tbill (MD 11/12/2025)

  • 182 Days Tbill (MD 12/02/2026)

  • 91 Days Tbill (MD 19/02/2026)

  • 91 Days Tbill (MD 08/01/2026)

  • 364 Days Tbill (MD 05/02/2026)

  • 91 Days Tbill (MD 26/02/2026)

  • Dr. Reddy's Laboratories Limited

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Plastic Products

  • Chemicals

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About WhiteOak Capital Pharma and Healthcare Fund

Scheme Analysis

WhiteOak Capital Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to WhiteOak Capital Mutual Fund. It was launched on 06-Feb-2024 and currently has an AUM of ₹501.89 crore. WhiteOak Capital Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of WhiteOak Capital Pharma and Healthcare Fund ended up ₹0.01(0.07%)yesterday to ₹13.917.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The WhiteOak Capital Pharma and Healthcare Fund is managed by Piyush Baranwal and Ramesh Mantri.

Fund House Contact

Unit No. B4, 6th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025

022-6918 7607
022 69187643